News Sentiment

NXTG sentiment intelligence

Nextage Therapeutics Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 3 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.43 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

66/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+7.6% over one week, -11.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Celldex Therapeutics Discontinues Phase 2 Study of Barzolvolimab in Prurigo Nodularis After Missing Primary Endpoint

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 66/100 classification
One-week reaction 7.6% Price confirming higher
Trend fit Trend inactive -11.3% over four weeks
Fair value -38.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MT Newswires 1
Ynetnews 1
microdose.buzz 1

Event Lens

What the news is about

Classified themes
Earnings 2
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3